| (+)-alpha-tocopherol | increases expression | EXP | | 6480464 | alpha-Tocopherol results in increased expression of NOS3 mRNA; more ... | CTD | PMID:16949522 |
| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of NOS3 mRNA | CTD | PMID:20021702 PMID:20706672 |
| (-)-epigallocatechin 3-gallate | increases expression | EXP | | 6480464 | epigallocatechin gallate results in increased expression of NOS3 mRNA | CTD | PMID:20706672 |
| (-)-epigallocatechin 3-gallate | multiple interactions | EXP | | 6480464 | epigallocatechin gallate promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:20021702 |
| (R)-carnitine | increases expression | ISO | RGD:3186 | 6480464 | Carnitine results in increased expression of NOS3 | CTD | PMID:20123095 |
| (R)-mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased expression of NOS3 mRNA] | CTD | PMID:20493886 |
| (S)-nicotine | increases expression | EXP | | 6480464 | Nicotine results in increased expression of NOS3 mRNA | CTD | PMID:11166759 |
| 1,3-dinitrobenzene | increases expression | ISO | RGD:3186 | 6480464 | 3-dinitrobenzene results in increased expression of NOS3 mRNA | CTD | PMID:21983209 |
| 11-deoxycorticosterone | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Desoxycorticosterone results in decreased phosphorylation of NOS3 protein | CTD | PMID:14993198 |
| 11-deoxycorticosterone | multiple interactions | ISO | RGD:3186 | 6480464 | NOS3 protein inhibits the reaction [Desoxycorticosterone results in increased expression of VCAM1 protein] | CTD | PMID:11834524 |
| 11-deoxycorticosterone | increases expression | ISO | RGD:3186 | 6480464 | Desoxycorticosterone results in increased expression of NOS3 protein | CTD | PMID:16271043 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:10997 | 6480464 | Ethinyl Estradiol results in increased expression of NOS3 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:10997 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOS3 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with ESR1 protein] results in increased expression of NOS3 mRNA; more ... | CTD | PMID:14742696 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Cyclodextrins inhibits the reaction [Estradiol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:18296501 |
| 17beta-estradiol | multiple interactions | ISO | RGD:3186 | 6480464 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [Estradiol results in increased expression of NOS3 protein]; more ... | CTD | PMID:11583108 |
| 17beta-estradiol | increases expression | ISO | RGD:3186 | 6480464 | Estradiol results in increased expression of NOS3 protein | CTD | PMID:11583108 more ... |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NOS3 mRNA | CTD | PMID:11583108 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | 5,11-diethyl-5,6,11,12-tetrahydrochrysene-2,8-diol inhibits the reaction [[Estradiol co-treated with ESR2] results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:11583108 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of NOS3 mRNA | CTD | PMID:21513769 |
| 17beta-estradiol | increases expression | ISO | RGD:3186 | 6480464 | Estradiol results in increased expression of NOS3 protein | CTD | PMID:15358673 PMID:21092740 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of NOS3 protein | CTD | PMID:15358673 PMID:16840783 |
| 17beta-estradiol | multiple interactions | ISO | RGD:3186 | 6480464 | Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NOS3 protein] | CTD | PMID:15358673 |
| 17beta-estradiol | increases expression | ISO | RGD:3186 | 6480464 | Estradiol results in increased expression of NOS3 protein | CTD | PMID:21092740 PMID:15358673 |
| 17beta-estradiol | affects expression | ISO | RGD:3186 | 6480464 | Estradiol affects the expression of NOS3 mRNA | CTD | PMID:12810170 |
| 17beta-estradiol | increases expression | ISO | RGD:3186 | 6480464 | Estradiol results in increased expression of NOS3 mRNA | CTD | PMID:11779577 |
| 17beta-estradiol | increases expression | ISO | RGD:10997 | 6480464 | Estradiol results in increased expression of NOS3 mRNA | CTD | PMID:17873880 |
| 17beta-estradiol | multiple interactions | ISO | RGD:10997 | 6480464 | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:17873880 |
| 17beta-estradiol | multiple interactions | EXP | | 6480464 | Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased activity of NOS3 protein]; more ... | CTD | PMID:15358673 |
| 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of NOS3 protein | CTD | PMID:15358673 |
| 17beta-estradiol | increases activity | EXP | | 6480464 | Estradiol results in increased activity of NOS3 protein | CTD | PMID:16840783 PMID:15358673 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | increases activity | EXP | | 6480464 | nebivolol results in increased activity of NOS3 protein | CTD | PMID:17977009 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | multiple interactions | ISO | RGD:3186 | 6480464 | [nebivolol co-treated with Flutamide] results in increased expression of NOS3 protein | CTD | PMID:19962728 |
| 2,2'-iminobis[1-(6-fluoro-3,4-dihydro-2H-chromen-2-yl)ethanol] | increases expression | ISO | RGD:3186 | 6480464 | nebivolol results in increased expression of NOS3 protein | CTD | PMID:19962728 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA] | CTD | PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA | CTD | PMID:11007951 more ... |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:10997 | 6480464 | Tetrachlorodibenzodioxin affects the expression of NOS3 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA | CTD | PMID:11007951 PMID:20106945 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:10997 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA | CTD | PMID:19933214 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA | CTD | PMID:20106945 PMID:11007951 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:10997 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of NOS3 mRNA | CTD | PMID:17942748 |
| 2,4,6-trinitrotoluene | affects expression | ISO | RGD:3186 | 6480464 | Trinitrotoluene affects the expression of NOS3 mRNA | CTD | PMID:21346803 |
| 2-acetamidofluorene | increases expression | ISO | RGD:10997 | 6480464 | 2-Acetylaminofluorene results in increased expression of NOS3 mRNA | CTD | PMID:17317680 |
| 2-acetamidofluorene | multiple interactions | ISO | RGD:10997 | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene results in increased expression of NOS3 mRNA] | CTD | PMID:17317680 |
| 2-butoxyethanol | increases expression | ISO | RGD:10997 | 6480464 | n-butoxyethanol results in increased expression of NOS3 mRNA | CTD | PMID:19812364 |
| 25-hydroxycholesterol | decreases expression | EXP | | 6480464 | 25-hydroxycholesterol results in decreased expression of NOS3 mRNA | CTD | PMID:19426978 |
| 26-hydroxycholesterol | multiple interactions | ISO | RGD:10997 | 6480464 | 27-hydroxycholesterol inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:17873880 |
| 26-hydroxycholesterol | decreases expression | ISO | RGD:10997 | 6480464 | 27-hydroxycholesterol results in decreased expression of NOS3 mRNA | CTD | PMID:17873880 |
| 3',5'-cyclic GMP | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 protein affects the reaction [Ramipril results in increased abundance of Cyclic GMP] | CTD | PMID:16891913 |
| 3',5'-cyclic GMP | increases abundance | ISO | RGD:3186 | 6480464 | NOS3 protein results in increased abundance of Cyclic GMP | CTD | PMID:11504159 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | increases expression | ISO | RGD:3186 | 6480464 | Puromycin Aminonucleoside results in increased expression of NOS3 mRNA | CTD | PMID:15039144 |
| 3'-amino-3'-deoxy-N(6),N(6)-dimethyladenosine | multiple interactions | ISO | RGD:3186 | 6480464 | Puromycin Aminonucleoside results in decreased expression of and results in decreased activity of NOS3 protein | CTD | PMID:15039144 |
| 3,3',4,4',5-pentachlorobiphenyl | multiple interactions | EXP | | 6480464 | [Estradiol co-treated with 3,4,5,3',4'-pentachlorobiphenyl] results in increased expression of NOS3 mRNA | CTD | PMID:21513769 |
| 4-coumaric acid | increases expression | EXP | | 6480464 | 4-coumaric acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| 5,6,7,8-tetrahydrobiopterin | multiple interactions | EXP | | 6480464 | 5,6,7,8-tetrahydrobiopterin deficiency inhibits the reaction [NOS3 protein results in increased abundance of Superoxides]; more ... | CTD | PMID:19011239 |
| 5-aza-2'-deoxycytidine | increases expression | EXP | | 6480464 | decitabine results in increased expression of NOS3 mRNA | CTD | PMID:16367923 |
| acetylcholine | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Acetylcholine | CTD | PMID:17403420 |
| acetylcholine | multiple interactions | ISO | RGD:3186 | 6480464 | NOS3 protein results in increased susceptibility to [Acetylcholine co-treated with Phenylephrine] | CTD | PMID:10954898 |
| acetylcholine | increases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in increased susceptibility to Acetylcholine | CTD | PMID:15381055 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [everolimus results in decreased expression of NOS3 protein]; more ... | CTD | PMID:19520256 |
| acetylsalicylic acid | multiple interactions | EXP | | 6480464 | Aspirin results in increased acetylation of and results in increased activity of NOS3 protein; more ... | CTD | PMID:20705923 |
| all-trans-retinoic acid | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:16043647 |
| all-trans-retinoic acid | increases phosphorylation | EXP | | 6480464 | Tretinoin results in increased phosphorylation of NOS3 protein | CTD | PMID:16043647 |
| all-trans-retinol | increases expression | ISO | RGD:3186 | 6480464 | Vitamin A deficiency results in increased expression of NOS3 | CTD | PMID:16036340 |
| allopurinol | multiple interactions | ISO | RGD:3186 | 6480464 | Allopurinol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:21912612 |
| aminoguanidine | affects expression | ISO | RGD:10997 | 6480464 | pimagedine affects the expression of NOS3 mRNA | CTD | PMID:18483403 |
| aminoguanidine | multiple interactions | ISO | RGD:10997 | 6480464 | pimagedine inhibits the reaction [Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein] | CTD | PMID:18483403 |
| amiodarone | multiple interactions | EXP | | 6480464 | Amiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:16479044 |
| amlodipine | increases expression | ISO | RGD:3186 | 6480464 | Amlodipine results in increased expression of NOS3 protein | CTD | PMID:16392774 |
| amlodipine | increases expression | ISO | RGD:3186 | 6480464 | Amlodipine results in increased expression of NOS3 mRNA | CTD | PMID:10445667 PMID:16392774 |
| amlodipine | increases expression | ISO | RGD:3186 | 6480464 | Amlodipine results in increased expression of NOS3 mRNA | CTD | PMID:10445667 |
| amlodipine | increases expression | ISO | RGD:3186 | 6480464 | Amlodipine results in increased expression of NOS3 mRNA | CTD | PMID:16392774 PMID:10445667 |
| ammonium chloride | affects expression | ISO | RGD:3186 | 6480464 | Ammonium Chloride affects the expression of NOS3 mRNA | CTD | PMID:16483693 |
| ammonium chloride | increases expression | ISO | RGD:3186 | 6480464 | Ammonium Chloride results in increased expression of NOS3 protein | CTD | PMID:16483693 |
| apocynin | multiple interactions | ISO | RGD:3186 | 6480464 | acetovanillone inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] | CTD | PMID:21983654 |
| apocynin | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein] | CTD | PMID:19878672 |
| arsenic atom | affects response to substance | EXP | | 6480464 | NOS3 gene polymorphism affects the susceptibility to Arsenic | CTD | PMID:16076760 |
| arsenic atom | decreases expression | ISO | RGD:3186 | 6480464 | Arsenic results in decreased expression of NOS3 mRNA | CTD | PMID:22120977 |
| arsenic atom | multiple interactions | ISO | RGD:3186 | 6480464 | Acetaminophen inhibits the reaction [Arsenic results in decreased expression of NOS3 mRNA] | CTD | PMID:22120977 |
| arsenic atom | decreases activity | ISO | RGD:3186 | 6480464 | Arsenic results in decreased activity of NOS3 protein | CTD | PMID:22120977 |
| arsenite(3-) | increases phosphorylation | EXP | | 6480464 | arsenite results in increased phosphorylation of NOS3 protein | CTD | PMID:22244921 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:11788791 |
| arsenite(3-) | multiple interactions | EXP | | 6480464 | arsenite inhibits the reaction [F2 protein results in increased phosphorylation of NOS3 protein]; more ... | CTD | PMID:22244921 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:10997 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in increased expression of NOS3 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | increases expression | ISO | RGD:3186 | 6480464 | Benzo(a)pyrene results in increased expression of NOS3 mRNA | CTD | PMID:22374506 |
| benzo[a]pyrene | affects expression | ISO | RGD:3186 | 6480464 | Benzo(a)pyrene affects the expression of NOS3 protein | CTD | PMID:22374506 |
| benzo[a]pyrene | increases expression | ISO | RGD:10997 | 6480464 | Benzo(a)pyrene results in increased expression of NOS3 mRNA | CTD | PMID:21569818 |
| benzoic acid | increases expression | EXP | | 6480464 | Benzoic Acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| bezafibrate | multiple interactions | ISO | RGD:10997 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Bezafibrate results in increased phosphorylation of NOS3 protein]; more ... | CTD | PMID:21499286 |
| bezafibrate | increases phosphorylation | ISO | RGD:10997 | 6480464 | Bezafibrate results in increased phosphorylation of NOS3 protein | CTD | PMID:21499286 |
| bis(2-chloroethyl) sulfide | multiple interactions | EXP | | 6480464 | Mustard Gas affects the localization of and results in increased activity of NOS3 protein | CTD | PMID:19397961 |
| bisphenol A | increases phosphorylation | EXP | | 6480464 | bisphenol A results in increased phosphorylation of NOS3 protein | CTD | PMID:22045264 |
| bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NOS3 mRNA | CTD | PMID:22045264 |
| C60 fullerene | increases expression | ISO | RGD:3186 | 6480464 | fullerene C60 results in increased expression of NOS3 mRNA | CTD | PMID:19167457 |
| cadmium atom | multiple interactions | ISO | RGD:3186 | 6480464 | Quercetin promotes the reaction [Cadmium results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:16226777 |
| cadmium dichloride | decreases expression | ISO | RGD:3186 | 6480464 | Cadmium Chloride results in decreased expression of NOS3 protein | CTD | PMID:18155860 |
| calcitriol | decreases expression | ISO | RGD:3186 | 6480464 | Calcitriol results in decreased expression of NOS3 protein | CTD | PMID:19092814 |
| calcium atom | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Calcium | CTD | PMID:17403420 |
| calcium atom | multiple interactions | EXP | | 6480464 | Calcium affects the reaction [Polycyclic Hydrocarbons, Aromatic results in increased expression of and results in increased activity of NOS3 protein] | CTD | PMID:15183461 |
| calcium atom | increases activity | EXP | | 6480464 | Calcium results in increased activity of NOS3 protein | CTD | PMID:22244921 |
| calcium atom | affects response to substance | ISO | RGD:3186 | 6480464 | NOS3 protein affects the susceptibility to Calcium | CTD | PMID:19380615 |
| calcium atom | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] | CTD | PMID:19446813 |
| calcium(0) | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Calcium | CTD | PMID:17403420 |
| calcium(0) | multiple interactions | EXP | | 6480464 | Calcium affects the reaction [Polycyclic Hydrocarbons, Aromatic results in increased expression of and results in increased activity of NOS3 protein] | CTD | PMID:15183461 |
| calcium(0) | increases activity | EXP | | 6480464 | Calcium results in increased activity of NOS3 protein | CTD | PMID:22244921 |
| calcium(0) | affects response to substance | ISO | RGD:3186 | 6480464 | NOS3 protein affects the susceptibility to Calcium | CTD | PMID:19380615 |
| calcium(0) | multiple interactions | EXP | | 6480464 | Calcium deficiency inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] | CTD | PMID:19446813 |
| candesartan | multiple interactions | EXP | | 6480464 | [PD 123319 binds to and results in decreased activity of AGTR2 protein] inhibits the reaction [candesartan results in increased expression of NOS3 protein] | CTD | PMID:18551021 |
| candesartan | multiple interactions | ISO | RGD:3186 | 6480464 | candesartan inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:16139267 |
| candesartan | multiple interactions | ISO | RGD:10997 | 6480464 | candesartan inhibits the reaction [AGT results in increased expression of NOS3 protein] | CTD | PMID:12065685 |
| capsaicin | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Capsaicin results in increased expression of NOS3 protein]; more ... | CTD | PMID:19846903 |
| capsaicin | decreases expression | ISO | RGD:3186 | 6480464 | Capsaicin results in decreased expression of NOS3 mRNA | CTD | PMID:16278290 PMID:18037908 |
| capsaicin | decreases expression | ISO | RGD:3186 | 6480464 | Capsaicin results in decreased expression of NOS3 mRNA | CTD | PMID:18037908 |
| capsaicin | decreases expression | ISO | RGD:3186 | 6480464 | Capsaicin results in decreased expression of NOS3 mRNA | CTD | PMID:18037908 PMID:16278290 |
| capsaicin | increases expression | EXP | | 6480464 | Capsaicin results in increased expression of NOS3 protein | CTD | PMID:19846903 |
| carbon monoxide | multiple interactions | ISO | RGD:3186 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein] | CTD | PMID:19356108 |
| carvedilol | increases expression | ISO | RGD:3186 | 6480464 | carvedilol results in increased expression of NOS3 mRNA | CTD | PMID:18971572 PMID:17559835 |
| carvedilol | increases phosphorylation | ISO | RGD:3186 | 6480464 | carvedilol results in increased phosphorylation of NOS3 protein | CTD | PMID:17559835 |
| carvedilol | increases expression | ISO | RGD:3186 | 6480464 | carvedilol results in increased expression of NOS3 protein | CTD | PMID:17559835 |
| carvedilol | decreases expression | ISO | RGD:3186 | 6480464 | carvedilol results in decreased expression of NOS3 mRNA | CTD | PMID:16741616 |
| carvedilol | increases expression | ISO | RGD:3186 | 6480464 | carvedilol results in increased expression of NOS3 mRNA | CTD | PMID:17559835 PMID:18971572 |
| chlorogenic acid | increases expression | EXP | | 6480464 | Chlorogenic Acid results in increased expression of NOS3 mRNA | CTD | PMID:20706672 |
| chromium atom | multiple interactions | ISO | RGD:3186 | 6480464 | [Niacin co-treated with Chromium] results in increased phosphorylation of NOS3 protein; more ... | CTD | PMID:19027847 |
| chromium atom | multiple interactions | ISO | RGD:3186 | 6480464 | Chromium inhibits the reaction [Sucrose results in decreased expression of NOS3 protein] | CTD | PMID:17215582 |
| cilostazol | multiple interactions | EXP | | 6480464 | cilostazol inhibits the reaction [everolimus results in decreased expression of NOS3 protein]; more ... | CTD | PMID:19520256 |
| cilostazol | increases phosphorylation | EXP | | 6480464 | cilostazol results in increased phosphorylation of NOS3 protein | CTD | PMID:18556572 |
| cinnamic acid | increases expression | EXP | | 6480464 | cinnamic acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| cis-caffeic acid | increases expression | EXP | | 6480464 | caffeic acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| cisplatin | multiple interactions | ISO | RGD:3186 | 6480464 | [Cisplatin co-treated with sildenafil] results in increased expression of NOS3 mRNA; more ... | CTD | PMID:19152827 |
| cobalt dichloride | increases expression | ISO | RGD:3186 | 6480464 | cobaltous chloride results in increased expression of NOS3 protein | CTD | PMID:22982409 |
| cocaine | decreases expression | EXP | | 6480464 | Cocaine results in decreased expression of NOS3 protein | CTD | PMID:18813882 |
| cocaine | decreases expression | ISO | RGD:3186 | 6480464 | Cocaine results in decreased expression of NOS3 protein | CTD | PMID:17420087 |
| cocaine | increases expression | ISO | RGD:3186 | 6480464 | Cocaine results in increased expression of NOS3 protein | CTD | PMID:19380615 |
| cocaine | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Cocaine results in decreased phosphorylation of NOS3 protein | CTD | PMID:19380615 |
| cocaine | multiple interactions | ISO | RGD:10997 | 6480464 | FOS protein mutant form inhibits the reaction [Cocaine results in increased expression of NOS3 mRNA] | CTD | PMID:18355967 |
| cocaine | increases expression | ISO | RGD:10997 | 6480464 | Cocaine results in increased expression of NOS3 mRNA | CTD | PMID:18355967 |
| curcumin | multiple interactions | EXP | | 6480464 | Curcumin inhibits the reaction [CXCL12 protein results in increased phosphorylation of NOS3 protein] | CTD | PMID:18660423 |
| cyanidin cation | increases expression | EXP | | 6480464 | cyanidin results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| cycloheximide | multiple interactions | EXP | | 6480464 | Cycloheximide inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NOS3 mRNA] | CTD | PMID:11007951 |
| cyclophosphamide | decreases activity | ISO | RGD:3186 | 6480464 | Cyclophosphamide results in decreased activity of NOS3 protein | CTD | PMID:9006340 |
| cyclophosphamide | increases expression | ISO | RGD:3186 | 6480464 | Cyclophosphamide results in increased expression of NOS3 protein | CTD | PMID:16125470 |
| cyclosporin A | increases expression | EXP | | 6480464 | Cyclosporine results in increased expression of NOS3 mRNA | CTD | PMID:12352326 |
| D-glucose | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; more ... | CTD | PMID:19767878 |
| D-glucose | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein] | CTD | PMID:19878672 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:15490108 more ... |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:15490108 more ... |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:15490108 PMID:20960276 |
| D-glucose | multiple interactions | EXP | | 6480464 | cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of NOS3 protein] | CTD | PMID:19924377 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS3 mRNA | CTD | PMID:15490108 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:17075048 more ... |
| D-glucose | decreases phosphorylation | EXP | | 6480464 | Glucose results in decreased phosphorylation of NOS3 protein | CTD | PMID:11696579 PMID:19767878 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:20960276 PMID:15490108 |
| D-glucose | increases O-linked glycosylation | EXP | | 6480464 | Glucose results in increased O-linked glycosylation of NOS3 protein | CTD | PMID:11696579 |
| D-glucose | multiple interactions | EXP | | 6480464 | Glucose results in increased expression of and results in increased activity of NOS3 protein | CTD | PMID:15490108 |
| D-glucose | increases expression | ISO | RGD:3186 | 6480464 | Glucose results in increased expression of NOS3 mRNA; more ... | CTD | PMID:17090780 |
| D-glucose | multiple interactions | ISO | RGD:10997 | 6480464 | Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein; more ... | CTD | PMID:18483403 |
| D-glucose | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:20960276 |
| D-glucose | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein] | CTD | PMID:17855661 |
| D-glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS3 protein | CTD | PMID:10502298 |
| D-glucose | decreases phosphorylation | EXP | | 6480464 | Glucose results in decreased phosphorylation of NOS3 protein | CTD | PMID:19767878 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:17075048 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:20960276 |
| D-glucose | decreases expression | EXP | | 6480464 | Glucose deficiency results in decreased expression of NOS3 protein | CTD | PMID:17855661 |
| daidzein | increases activity | EXP | | 6480464 | daidzein results in increased activity of NOS3 protein | CTD | PMID:16840783 |
| dexamethasone | multiple interactions | ISO | RGD:10997 | 6480464 | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS3 protein | CTD | PMID:18030227 |
| dexamethasone | increases expression | EXP | | 6480464 | Dexamethasone results in increased expression of NOS3 mRNA | CTD | PMID:19853017 |
| dexamethasone | decreases expression | ISO | RGD:3186 | 6480464 | Dexamethasone results in decreased expression of NOS3 mRNA | CTD | PMID:17042910 PMID:14618091 |
| dexamethasone | increases expression | ISO | RGD:3186 | 6480464 | Dexamethasone results in increased expression of NOS3 mRNA | CTD | PMID:10484530 |
| dexamethasone | multiple interactions | ISO | RGD:3186 | 6480464 | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein] | CTD | PMID:20068362 |
| dexamethasone | decreases expression | ISO | RGD:3186 | 6480464 | Dexamethasone results in decreased expression of NOS3 protein | CTD | PMID:20068362 |
| dexamethasone | decreases expression | ISO | RGD:3186 | 6480464 | Dexamethasone results in decreased expression of NOS3 mRNA | CTD | PMID:14618091 PMID:17042910 |
| dexamethasone | multiple interactions | ISO | RGD:3186 | 6480464 | atorvastatin inhibits the reaction [Dexamethasone results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:17042910 |
| dexamethasone | increases response to substance | ISO | RGD:10997 | 6480464 | NOS3 gene mutant form results in increased susceptibility to Dexamethasone | CTD | PMID:18030227 |
| dexamethasone | decreases expression | ISO | RGD:10997 | 6480464 | Dexamethasone results in decreased expression of NOS3 mRNA | CTD | PMID:15050533 |
| diarsenic trioxide | decreases expression | EXP | | 6480464 | arsenic trioxide results in decreased expression of NOS3 protein | CTD | PMID:17559834 |
| diarsenic trioxide | multiple interactions | EXP | | 6480464 | arsenic trioxide results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:18414637 |
| diarsenic trioxide | increases expression | EXP | | 6480464 | arsenic trioxide results in increased expression of NOS3 mRNA | CTD | PMID:20458559 |
| diazoxide | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA] | CTD | PMID:12224825 |
| diazoxide | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:16702995 PMID:19168511 |
| diazoxide | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:19168511 PMID:16702995 |
| diazoxide | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:19168511 |
| diazoxide | decreases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in decreased expression of NOS3 mRNA | CTD | PMID:18816294 |
| diazoxide | multiple interactions | ISO | RGD:3186 | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol affects the expression of NOS3 mRNA]; more ... | CTD | PMID:17996136 |
| diazoxide | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Isoproterenol | CTD | PMID:17403420 |
| dichlorine | decreases activity | ISO | RGD:3186 | 6480464 | Chlorine results in decreased activity of NOS3 protein | CTD | PMID:21131444 |
| dichlorine | decreases expression | ISO | RGD:3186 | 6480464 | Chlorine results in decreased expression of NOS3 protein | CTD | PMID:21131444 |
| digitoxin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin results in increased activity of NOS3 protein]; more ... | CTD | PMID:19446813 |
| digitoxin | increases activity | EXP | | 6480464 | Digitoxin results in increased activity of NOS3 protein | CTD | PMID:19446813 |
| digoxin | decreases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in decreased susceptibility to Digoxin | CTD | PMID:11761419 |
| dioxygen | decreases activity | EXP | | 6480464 | Oxygen deficiency results in decreased activity of NOS3 protein | CTD | PMID:18001528 |
| dioxygen | increases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in increased expression of NOS3 protein | CTD | PMID:10747003 PMID:10956627 |
| dioxygen | decreases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in decreased expression of NOS3 protein | CTD | PMID:10747003 PMID:10956627 |
| dioxygen | increases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in increased expression of NOS3 protein | CTD | PMID:10956627 PMID:10747003 |
| dioxygen | decreases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in decreased expression of NOS3 protein | CTD | PMID:10956627 PMID:10747003 |
| dioxygen | increases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in increased expression of NOS3 mRNA | CTD | PMID:12829860 |
| dioxygen | increases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in increased expression of NOS3 protein | CTD | PMID:10747003 |
| dioxygen | decreases expression | ISO | RGD:3186 | 6480464 | Oxygen deficiency results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:10747003 |
| dioxygen | multiple interactions | ISO | RGD:10997 | 6480464 | valsartan inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NOS3 protein] | CTD | PMID:18436887 |
| dioxygen | multiple interactions | ISO | RGD:3186 | 6480464 | Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]; more ... | CTD | PMID:11897773 |
| dioxygen | decreases expression | EXP | | 6480464 | Oxygen deficiency results in decreased expression of NOS3 mRNA | CTD | PMID:18001528 |
| dioxygen | increases phosphorylation | ISO | RGD:10997 | 6480464 | Oxygen deficiency results in increased phosphorylation of NOS3 protein | CTD | PMID:18436887 |
| doxorubicin | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 protein affects the reaction [Doxorubicin results in increased abundance of Reactive Oxygen Species] | CTD | PMID:17638931 |
| doxorubicin | decreases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in decreased susceptibility to Doxorubicin | CTD | PMID:12591762 |
| doxorubicin | increases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in increased susceptibility to Doxorubicin | CTD | PMID:19308358 |
| doxorubicin | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Doxorubicin | CTD | PMID:17638931 |
| edaravone | increases expression | ISO | RGD:3186 | 6480464 | phenylmethylpyrazolone results in increased expression of NOS3 protein; more ... | CTD | PMID:12969758 |
| edaravone | decreases degradation | EXP | | 6480464 | phenylmethylpyrazolone results in decreased degradation of NOS3 mRNA | CTD | PMID:15721014 |
| enalapril | multiple interactions | ISO | RGD:3186 | 6480464 | Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein] | CTD | PMID:16197366 |
| enalapril | multiple interactions | ISO | RGD:10997 | 6480464 | [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein | CTD | PMID:20720404 |
| enalapril | increases expression | ISO | RGD:10997 | 6480464 | Enalapril results in increased expression of NOS3 protein | CTD | PMID:20720404 |
| enalapril | affects expression | ISO | RGD:3186 | 6480464 | Enalapril affects the expression of NOS3 mRNA | CTD | PMID:12176110 PMID:20571278 |
| enalapril | multiple interactions | ISO | RGD:3186 | 6480464 | [Enalapril co-treated with eplerenone] results in decreased expression of NOS3 mRNA | CTD | PMID:20571278 |
| enalapril | affects expression | ISO | RGD:3186 | 6480464 | Enalapril affects the expression of NOS3 mRNA | CTD | PMID:20571278 PMID:12176110 |
| estriol | increases expression | EXP | | 6480464 | Estriol results in increased expression of NOS3 mRNA; more ... | CTD | PMID:12547825 |
| ethanol | decreases expression | ISO | RGD:3186 | 6480464 | Ethanol results in decreased expression of NOS3 protein | CTD | PMID:18037914 |
| ethanol | increases expression | ISO | RGD:3186 | 6480464 | Ethanol results in increased expression of NOS3 protein | CTD | PMID:19615717 PMID:18284813 |
| ethanol | increases expression | ISO | RGD:3186 | 6480464 | Ethanol results in increased expression of NOS3 protein | CTD | PMID:18284813 PMID:19615717 |
| ethanol | increases expression | ISO | RGD:3186 | 6480464 | Ethanol results in increased expression of NOS3 mRNA | CTD | PMID:19615717 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | decreases expression | EXP | | 6480464 | Egtazic Acid results in decreased expression of NOS3 mRNA | CTD | PMID:20020783 |
| ethylene glycol bis(2-aminoethyl)tetraacetic acid | decreases expression | EXP | | 6480464 | Egtazic Acid results in decreased expression of NOS3 | CTD | PMID:19837105 |
| everolimus | decreases expression | EXP | | 6480464 | everolimus results in decreased expression of NOS3 protein | CTD | PMID:19520256 |
| everolimus | multiple interactions | EXP | | 6480464 | cilostazol inhibits the reaction [everolimus results in decreased expression of NOS3 protein]; more ... | CTD | PMID:19520256 |
| fenofibrate | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [wortmannin results in decreased phosphorylation of NOS3 protein] | CTD | PMID:16442496 |
| fenofibrate | increases phosphorylation | EXP | | 6480464 | Fenofibrate results in increased phosphorylation of NOS3 protein | CTD | PMID:16442496 PMID:20580385 |
| fenofibrate | increases phosphorylation | EXP | | 6480464 | Fenofibrate results in increased phosphorylation of NOS3 protein | CTD | PMID:20580385 PMID:16442496 |
| fenofibrate | increases activity | EXP | | 6480464 | Fenofibrate results in increased activity of NOS3 protein | CTD | PMID:20580385 |
| fenofibrate | multiple interactions | EXP | | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [Fenofibrate results in increased activity of NOS3 protein]; more ... | CTD | PMID:20580385 |
| fenofibrate | increases phosphorylation | EXP | | 6480464 | Fenofibrate results in increased phosphorylation of NOS3 protein | CTD | PMID:16442496 |
| fluoranthene | increases expression | EXP | | 6480464 | fluoranthene results in increased expression of NOS3 mRNA; more ... | CTD | PMID:15183461 |
| fluoranthene | multiple interactions | EXP | | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluoranthene results in increased expression of NOS3 protein]; more ... | CTD | PMID:15183461 |
| fluorene | increases expression | EXP | | 6480464 | fluorene results in increased expression of NOS3 protein; more ... | CTD | PMID:15183461 |
| fluorene | multiple interactions | EXP | | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [fluorene results in increased expression of NOS3 protein]; more ... | CTD | PMID:15183461 |
| flutamide | multiple interactions | ISO | RGD:3186 | 6480464 | [nebivolol co-treated with Flutamide] results in increased expression of NOS3 protein | CTD | PMID:19962728 |
| formaldehyde | multiple interactions | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:21983654 |
| formaldehyde | increases expression | ISO | RGD:3186 | 6480464 | Formaldehyde results in increased expression of NOS3 mRNA | CTD | PMID:21983654 |
| formononetin | increases expression | ISO | RGD:3186 | 6480464 | formononetin results in increased expression of NOS3 mRNA | CTD | PMID:19570671 |
| formononetin | multiple interactions | ISO | RGD:3186 | 6480464 | formononetin results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:19570671 |
| fosinopril | affects expression | ISO | RGD:3186 | 6480464 | Fosinopril affects the expression of NOS3 mRNA; more ... | CTD | PMID:18209565 |
| fructose | multiple interactions | ISO | RGD:3186 | 6480464 | Fish Oils inhibits the reaction [Fructose results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:15752949 |
| fructose | multiple interactions | ISO | RGD:3186 | 6480464 | NOS3 protein inhibits the reaction [Fructose results in decreased expression of IRS1 protein]; more ... | CTD | PMID:19008412 |
| fructose | decreases activity | ISO | RGD:3186 | 6480464 | Fructose results in decreased activity of NOS3 protein | CTD | PMID:10580434 |
| fructose | decreases expression | ISO | RGD:3186 | 6480464 | Fructose results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:15752949 |
| fructose | decreases expression | EXP | | 6480464 | Fructose results in decreased expression of NOS3 protein | CTD | PMID:18508964 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [[Estradiol co-treated with ESR1 protein] results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:14742696 |
| fulvestrant | multiple interactions | EXP | | 6480464 | [fulvestrant co-treated with L 663536] inhibits the reaction [resveratrol results in increased expression of NOS3 mRNA] | CTD | PMID:21791144 |
| fulvestrant | multiple interactions | ISO | RGD:3186 | 6480464 | fulvestrant inhibits the reaction [Estradiol results in increased expression of NOS3 protein] | CTD | PMID:11583108 |
| fulvestrant | multiple interactions | EXP | | 6480464 | fulvestrant inhibits the reaction [puerarin results in increased phosphorylation of NOS3 protein]; more ... | CTD | PMID:21884717 |
| fulvestrant | decreases expression | ISO | RGD:3186 | 6480464 | fulvestrant results in decreased expression of NOS3 protein | CTD | PMID:19962728 |
| furosemide | affects expression | ISO | RGD:3186 | 6480464 | Furosemide affects the expression of NOS3 mRNA | CTD | PMID:16526316 |
| genistein | increases activity | EXP | | 6480464 | Genistein results in increased activity of NOS3 protein | CTD | PMID:16840783 |
| genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of NOS3 mRNA | CTD | PMID:20021702 |
| genistein | multiple interactions | EXP | | 6480464 | Genistein inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:20021702 |
| genistein | increases expression | EXP | | 6480464 | Genistein results in increased expression of NOS3 mRNA | CTD | PMID:20706672 |
| gliclazide | increases expression | ISO | RGD:3186 | 6480464 | Gliclazide results in increased expression of NOS3 protein | CTD | PMID:14871415 |
| glucose | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; more ... | CTD | PMID:19767878 |
| glucose | multiple interactions | EXP | | 6480464 | acetovanillone inhibits the reaction [Glucose results in decreased expression of NOS3 protein] | CTD | PMID:19878672 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:15490108 more ... |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:15490108 more ... |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:15490108 PMID:20960276 |
| glucose | multiple interactions | EXP | | 6480464 | cobaltiprotoporphyrin inhibits the reaction [Glucose results in decreased expression of NOS3 protein] | CTD | PMID:19924377 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS3 mRNA | CTD | PMID:15490108 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:17075048 more ... |
| glucose | decreases phosphorylation | EXP | | 6480464 | Glucose results in decreased phosphorylation of NOS3 protein | CTD | PMID:11696579 PMID:19767878 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:20960276 PMID:15490108 |
| glucose | increases O-linked glycosylation | EXP | | 6480464 | Glucose results in increased O-linked glycosylation of NOS3 protein | CTD | PMID:11696579 |
| glucose | multiple interactions | EXP | | 6480464 | Glucose results in increased expression of and results in increased activity of NOS3 protein | CTD | PMID:15490108 |
| glucose | increases expression | ISO | RGD:3186 | 6480464 | Glucose results in increased expression of NOS3 mRNA; more ... | CTD | PMID:17090780 |
| glucose | multiple interactions | ISO | RGD:10997 | 6480464 | Glucose results in decreased expression of and results in decreased phosphorylation of NOS3 protein; more ... | CTD | PMID:18483403 |
| glucose | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:20960276 |
| glucose | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein] | CTD | PMID:17855661 |
| glucose | increases expression | EXP | | 6480464 | Glucose results in increased expression of NOS3 protein | CTD | PMID:10502298 |
| glucose | decreases phosphorylation | EXP | | 6480464 | Glucose results in decreased phosphorylation of NOS3 protein | CTD | PMID:19767878 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 protein | CTD | PMID:17075048 |
| glucose | decreases expression | EXP | | 6480464 | Glucose results in decreased expression of NOS3 mRNA | CTD | PMID:20960276 |
| glucose | decreases expression | EXP | | 6480464 | Glucose deficiency results in decreased expression of NOS3 protein | CTD | PMID:17855661 |
| glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein] which results in decreased abundance of Nitric Oxide; more ... | CTD | PMID:20020783 |
| glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | Calcimycin inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA] | CTD | PMID:19837105 PMID:20020783 |
| glycochenodeoxycholic acid | decreases expression | EXP | | 6480464 | Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein; more ... | CTD | PMID:19837105 PMID:20020783 |
| glycochenodeoxycholic acid | decreases expression | EXP | | 6480464 | Glycochenodeoxycholic Acid results in decreased expression of NOS3 | CTD | PMID:19837105 |
| glycochenodeoxycholic acid | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:19837105 |
| glycochenodeoxycholic acid | decreases expression | EXP | | 6480464 | Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:20020783 |
| hemin | multiple interactions | ISO | RGD:3186 | 6480464 | [Nitroglycerin co-treated with Hemin] results in increased expression of NOS3 mRNA | CTD | PMID:17541025 |
| hexacosan-1-ol | multiple interactions | ISO | RGD:3186 | 6480464 | 1-hexacosanol inhibits the reaction [Streptozocin results in decreased expression of NOS3 protein] | CTD | PMID:18528636 |
| hydrogen chloride | decreases expression | ISO | RGD:3186 | 6480464 | Hydrochloric Acid results in decreased expression of NOS3 protein | CTD | PMID:12771618 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | catalase-polyethylene glycol inhibits the reaction [Hydrogen Peroxide results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:19105596 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of NOS3 mRNA | CTD | PMID:18234130 PMID:20021702 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:22358095 |
| hydrogen peroxide | decreases activity | EXP | | 6480464 | Hydrogen Peroxide results in decreased activity of NOS3 protein | CTD | PMID:22358095 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | epigallocatechin gallate promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:20021702 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of NOS3 protein | CTD | PMID:14607919 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:20562903 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Simvastatin promotes the reaction [[Hydrogen Peroxide co-treated with Nifedipine] results in increased phosphorylation of and results in increased expression of NOS3 protein]]; more ... | CTD | PMID:20562903 |
| hydrogen peroxide | increases expression | EXP | | 6480464 | Hydrogen Peroxide results in increased expression of NOS3 mRNA | CTD | PMID:18234130 |
| hydrogen peroxide | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:18234130 |
| hydrogen peroxide | decreases expression | EXP | | 6480464 | Hydrogen Peroxide results in decreased expression of NOS3 mRNA | CTD | PMID:19105596 PMID:20562903 |
| indomethacin | multiple interactions | ISO | RGD:10997 | 6480464 | [Dexamethasone co-treated with Indomethacin] results in decreased expression of NOS3 protein | CTD | PMID:18030227 |
| indomethacin | multiple interactions | ISO | RGD:3186 | 6480464 | Indomethacin inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] | CTD | PMID:21983654 |
| indomethacin | increases expression | ISO | RGD:3186 | 6480464 | Indomethacin results in increased expression of NOS3 protein | CTD | PMID:15053815 |
| indomethacin | increases expression | ISO | RGD:10997 | 6480464 | Indomethacin results in increased expression of NOS3 mRNA | CTD | PMID:18297107 |
| indomethacin | decreases expression | ISO | RGD:10997 | 6480464 | Indomethacin results in decreased expression of NOS3 protein | CTD | PMID:18030227 |
| isoprenaline | multiple interactions | ISO | RGD:3186 | 6480464 | 3-(2-ethylphenoxy)-1-(1,2,3,4-tetrahydronaphth-1-ylamino)-2-propanol oxalate inhibits the reaction [Isoproterenol affects the expression of NOS3 mRNA]; more ... | CTD | PMID:17996136 |
| isoprenaline | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:16702995 PMID:19168511 |
| isoprenaline | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:19168511 PMID:16702995 |
| isoprenaline | increases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in increased expression of NOS3 protein | CTD | PMID:19168511 |
| isoprenaline | decreases expression | ISO | RGD:3186 | 6480464 | Isoproterenol results in decreased expression of NOS3 mRNA | CTD | PMID:18816294 |
| isoprenaline | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Isoproterenol | CTD | PMID:17403420 |
| isoprenaline | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 inhibits the reaction [Isoproterenol results in increased expression of NPPA mRNA] | CTD | PMID:12224825 |
| isorhamnetin | multiple interactions | EXP | | 6480464 | 3-methylquercetin inhibits the reaction [Lipids results in decreased expression of NOS3] | CTD | PMID:16891912 |
| isosorbide dinitrate | multiple interactions | EXP | | 6480464 | [Isosorbide Dinitrate co-treated with Ascorbic Acid] affects the expression of NOS3 mRNA; more ... | CTD | PMID:15719745 |
| L-ascorbic acid | multiple interactions | ISO | RGD:3186 | 6480464 | Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein] | CTD | PMID:11729227 |
| L-ascorbic acid | increases phosphorylation | ISO | RGD:10997 | 6480464 | Ascorbic Acid results in increased phosphorylation of NOS3 protein | CTD | PMID:21570463 |
| L-ascorbic acid | multiple interactions | ISO | RGD:3186 | 6480464 | [Vitamin E co-treated with Ascorbic Acid] inhibits the reaction [Dexamethasone results in decreased expression of NOS3 protein] | CTD | PMID:20068362 |
| L-ascorbic acid | multiple interactions | EXP | | 6480464 | [Isosorbide Dinitrate co-treated with Ascorbic Acid] affects the expression of NOS3 mRNA | CTD | PMID:15719745 |
| L-erythro-7,8-dihydrobiopterin | multiple interactions | EXP | | 6480464 | 7,8-dihydrobiopterin promotes the reaction [NOS3 protein results in increased abundance of Superoxides] | CTD | PMID:19011239 |
| lactic acid | affects transport | EXP | | 6480464 | NOS3 protein affects the transport of Lactic Acid | CTD | PMID:16032374 |
| lead diacetate | increases expression | EXP | | 6480464 | lead acetate results in increased expression of NOS3 protein | CTD | PMID:11230275 |
| lead diacetate | increases expression | ISO | RGD:3186 | 6480464 | lead acetate results in increased expression of NOS3 protein | CTD | PMID:11454931 PMID:11729227 |
| lead diacetate | increases expression | ISO | RGD:3186 | 6480464 | lead acetate results in increased expression of NOS3 protein | CTD | PMID:11729227 PMID:11454931 |
| lead diacetate | multiple interactions | ISO | RGD:3186 | 6480464 | Ascorbic Acid inhibits the reaction [lead acetate results in increased expression of NOS3 protein] | CTD | PMID:11729227 |
| lead diacetate | multiple interactions | ISO | RGD:3186 | 6480464 | tempol inhibits the reaction [lead acetate results in increased expression of NOS3 protein] | CTD | PMID:11454931 |
| lead diacetate | multiple interactions | EXP | | 6480464 | U 74389F inhibits the reaction [lead acetate results in increased expression of NOS3 protein]; more ... | CTD | PMID:11230275 |
| lead(0) | increases expression | ISO | RGD:3186 | 6480464 | Lead results in increased expression of NOS3 protein | CTD | PMID:10523326 |
| lead(0) | increases phosphorylation | ISO | RGD:3186 | 6480464 | Lead results in increased phosphorylation of NOS3 protein | CTD | PMID:21364929 |
| lead(0) | multiple interactions | ISO | RGD:3186 | 6480464 | Vitamin E inhibits the reaction [Lead results in increased expression of NOS3 protein] | CTD | PMID:10523326 |
| losartan | affects expression | ISO | RGD:3186 | 6480464 | Losartan affects the expression of NOS3 mRNA | CTD | PMID:12198324 |
| losartan | increases expression | ISO | RGD:3186 | 6480464 | Losartan results in increased expression of NOS3 mRNA | CTD | PMID:18971572 |
| losartan | multiple interactions | ISO | RGD:3186 | 6480464 | Losartan inhibits the reaction [Sodium Chloride results in decreased expression of NOS3 protein] | CTD | PMID:20232302 |
| losartan | increases phosphorylation | ISO | RGD:3186 | 6480464 | Losartan results in increased phosphorylation of NOS3 protein | CTD | PMID:18390819 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:22314268 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein] | CTD | PMID:11788791 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cholesterol-3-beta,5-alpha, 6-beta-triol results in increased phosphorylation of NOS3 protein] | CTD | PMID:19616084 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]]; more ... | CTD | PMID:20562903 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; more ... | CTD | PMID:19767878 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Digitoxin results in increased activity of NOS3 protein] | CTD | PMID:19446813 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Cholesterol, HDL results in increased phosphorylation of and results in increased activity of AKT1 protein] which results in decreased degradation of NOS3 protein] | CTD | PMID:12821261 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased phosphorylation of NOS3 protein]; more ... | CTD | PMID:19906781 |
| LY294002 | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:21884717 |
| LY294002 | multiple interactions | ISO | RGD:3186 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[Carbon Monoxide results in increased expression of ADIPOQ protein] which results in increased phosphorylation of NOS3 protein] | CTD | PMID:19356108 |
| manganese atom | multiple interactions | EXP | | 6480464 | Manganese inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein] | CTD | PMID:21300668 |
| manganese(0) | multiple interactions | EXP | | 6480464 | Manganese inhibits the reaction [Equol results in increased activity of and results in increased phosphorylation of NOS3 protein] | CTD | PMID:21300668 |
| medroxyprogesterone acetate | multiple interactions | EXP | | 6480464 | Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased activity of NOS3 protein]; more ... | CTD | PMID:15358673 |
| medroxyprogesterone acetate | multiple interactions | ISO | RGD:3186 | 6480464 | Medroxyprogesterone Acetate inhibits the reaction [Estradiol results in increased expression of NOS3 protein] | CTD | PMID:15358673 |
| melatonin | multiple interactions | EXP | | 6480464 | Melatonin inhibits the reaction [lipopolysaccharide, E coli O55-B5 results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:21585521 |
| menadione | decreases activity | ISO | RGD:3186 | 6480464 | Vitamin K 3 results in decreased activity of NOS3 protein | CTD | PMID:11551532 |
| methotrexate | affects response to substance | EXP | | 6480464 | NOS3 gene SNP affects the susceptibility to Methotrexate | CTD | PMID:16013960 |
| metoprolol | decreases expression | ISO | RGD:3186 | 6480464 | Metoprolol results in decreased expression of NOS3 protein | CTD | PMID:18703049 |
| mevalonic acid | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased expression of NOS3 mRNA] | CTD | PMID:20493886 |
| mifepristone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 protein]; more ... | CTD | PMID:15358673 |
| monocrotaline | multiple interactions | ISO | RGD:3186 | 6480464 | 4-chlorobenzyltetrahydroberberine inhibits the reaction [Monocrotaline results in decreased activity of NOS3 protein]; more ... | CTD | PMID:16225752 |
| monocrotaline | increases expression | ISO | RGD:3186 | 6480464 | Monocrotaline results in increased expression of NOS3 mRNA | CTD | PMID:22022327 PMID:16225752 |
| monocrotaline | multiple interactions | ISO | RGD:3186 | 6480464 | Simvastatin inhibits the reaction [Monocrotaline results in increased expression of NOS3 mRNA] | CTD | PMID:22022327 |
| monocrotaline | increases expression | ISO | RGD:3186 | 6480464 | Monocrotaline results in increased expression of NOS3 mRNA | CTD | PMID:16225752 PMID:22022327 |
| monocrotaline | increases expression | ISO | RGD:3186 | 6480464 | Monocrotaline results in increased expression of NOS3 mRNA | CTD | PMID:16225752 |
| monocrotaline | decreases activity | ISO | RGD:3186 | 6480464 | Monocrotaline results in decreased activity of NOS3 protein | CTD | PMID:16225752 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3186 | 6480464 | Acetylcysteine inhibits the reaction [Triglycerides results in decreased expression of NOS3 protein]; more ... | CTD | PMID:16140881 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:3186 | 6480464 | Acetylcysteine inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:21912612 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:19837105 |
| N-acetyl-L-cysteine | multiple interactions | EXP | | 6480464 | Acetylcysteine inhibits the reaction [TNF results in decreased expression of NOS3 protein] | CTD | PMID:17026986 |
| N-acetyl-L-cysteine | increases expression | ISO | RGD:3186 | 6480464 | Acetylcysteine results in increased expression of NOS3 protein | CTD | PMID:17321519 |
| N-nitrosodimethylamine | decreases expression | ISO | RGD:3186 | 6480464 | Dimethylnitrosamine results in decreased expression of NOS3 protein | CTD | PMID:18364076 |
| N-nitrosodimethylamine | multiple interactions | ISO | RGD:3186 | 6480464 | Dimethylnitrosamine promotes the reaction [CAV1 protein binds to NOS3 protein] | CTD | PMID:18364076 |
| naphthalene | multiple interactions | EXP | | 6480464 | 1-(2-(3-(4-methoxyphenyl)propoxy)-4-methoxyphenylethyl)-1H-imidazole inhibits the reaction [naphthalene results in increased expression of NOS3 protein]; more ... | CTD | PMID:15183461 |
| naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of NOS3 mRNA; more ... | CTD | PMID:15183461 |
| nickel atom | increases activity | ISO | RGD:10997 | 6480464 | Nickel results in increased activity of NOS3 protein | CTD | PMID:12540486 |
| nickel dichloride | multiple interactions | EXP | | 6480464 | nickel chloride inhibits the reaction [fluorene results in increased expression of NOS3 protein]; more ... | CTD | PMID:15183461 |
| nicotinic acid | multiple interactions | ISO | RGD:3186 | 6480464 | [Niacin co-treated with Chromium] inhibits the reaction [CAV1 protein binds to NOS3 protein]; more ... | CTD | PMID:19027847 |
| nicotinic acid | increases phosphorylation | ISO | RGD:3186 | 6480464 | Niacin results in increased phosphorylation of NOS3 protein | CTD | PMID:17557352 |
| nicotinic acid | increases expression | ISO | RGD:10997 | 6480464 | Niacin results in increased expression of NOS3 mRNA | CTD | PMID:17557352 |
| nifedipine | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]]; more ... | CTD | PMID:20562903 |
| nitric oxide | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [[resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:22314268 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:22358095 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:21791144 |
| nitric oxide | multiple interactions | ISO | RGD:10997 | 6480464 | [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20675566 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12270858 PMID:18716157 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Estradiol results in increased phosphorylation of and results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide; more ... | CTD | PMID:18296501 |
| nitric oxide | multiple interactions | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency inhibits the reaction [Formaldehyde results in increased expression of NOS3 mRNA] | CTD | PMID:21983654 |
| nitric oxide | multiple interactions | EXP | | 6480464 | 1,2-bis(2-aminophenoxy)ethane N,N,N',N'-tetraacetic acid acetoxymethyl ester inhibits the reaction [[puerarin results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]; more ... | CTD | PMID:21884717 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS3 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:16479044 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | SOD1 protein inhibits the reaction [Nitric Oxide results in decreased activity of NOS3 protein] | CTD | PMID:12489993 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS3 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18556569 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | [NOS3 protein polymorphism results in decreased chemical synthesis of Nitric Oxide] which affects the expression of RCN1 protein; more ... | CTD | PMID:19320461 |
| nitric oxide | affects chemical synthesis | EXP | | 6480464 | NOS3 protein affects the chemical synthesis of Nitric Oxide | CTD | PMID:19696404 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Glycochenodeoxycholic Acid results in decreased expression of NOS3 protein] which results in decreased abundance of Nitric Oxide | CTD | PMID:20020783 |
| nitric oxide | decreases expression | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency results in decreased expression of NOS3 protein | CTD | PMID:16197366 PMID:15249212 |
| nitric oxide | multiple interactions | ISO | RGD:10997 | 6480464 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [[Bezafibrate results in increased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide] | CTD | PMID:21499286 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS3 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:16479044 more ... |
| nitric oxide | multiple interactions | ISO | RGD:10997 | 6480464 | [GULO protein co-treated with NOS3 protein] results in increased abundance of Nitric Oxide | CTD | PMID:16737683 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Hydrogen Peroxide results in decreased expression of NOS3 protein] which results in decreased secretion of Nitric Oxide; more ... | CTD | PMID:20562903 |
| nitric oxide | multiple interactions | ISO | RGD:3186 | 6480464 | Thioacetamide promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:15207323 |
| nitric oxide | multiple interactions | ISO | RGD:3186 | 6480464 | [sildenafil results in increased expression of NOS3 protein] which results in increased secretion of Nitric Oxide | CTD | PMID:19845545 |
| nitric oxide | increases chemical synthesis | ISO | RGD:3186 | 6480464 | NOS3 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:15207323 |
| nitric oxide | decreases expression | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency results in decreased expression of NOS3 protein | CTD | PMID:15249212 PMID:16197366 |
| nitric oxide | decreases expression | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency results in decreased expression of NOS3 mRNA | CTD | PMID:10445667 |
| nitric oxide | affects expression | ISO | RGD:3186 | 6480464 | Nitric Oxide deficiency affects the expression of NOS3 protein | CTD | PMID:19631198 |
| nitric oxide | multiple interactions | ISO | RGD:3186 | 6480464 | AGT protein alternative form promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18990443 |
| nitric oxide | multiple interactions | ISO | RGD:3186 | 6480464 | Enalapril inhibits the reaction [Nitric Oxide deficiency results in decreased expression of NOS3 protein]; more ... | CTD | PMID:16197366 |
| nitric oxide | multiple interactions | EXP | | 6480464 | [Trichloroethylene results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17719164 |
| nitric oxide | multiple interactions | EXP | | 6480464 | Tretinoin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:16043647 |
| nitric oxide | increases abundance | EXP | | 6480464 | NOS3 protein results in increased abundance of Nitric Oxide | CTD | PMID:19011239 |
| nitric oxide | multiple interactions | EXP | | 6480464 | NOX5 protein promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:18556569 |
| nitric oxide | decreases chemical synthesis | EXP | | 6480464 | NOS3 gene mutant form results in decreased chemical synthesis of Nitric Oxide | CTD | PMID:11740345 |
| nitric oxide | increases chemical synthesis | EXP | | 6480464 | NOS3 protein results in increased chemical synthesis of Nitric Oxide | CTD | PMID:18556569 more ... |
| nitric oxide | multiple interactions | EXP | | 6480464 | icariin promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:17499557 |
| nitric oxide | multiple interactions | EXP | | 6480464 | Amiodarone promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide]; more ... | CTD | PMID:16479044 |
| nitric oxide | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [[Glucose results in decreased phosphorylation of NOS3 protein] which results in increased abundance of Nitric Oxide]]; more ... | CTD | PMID:19767878 |
| nitroglycerin | multiple interactions | ISO | RGD:3186 | 6480464 | [Nitroglycerin co-treated with Hemin] results in increased expression of NOS3 mRNA | CTD | PMID:17541025 |
| nitroglycerin | increases expression | ISO | RGD:3186 | 6480464 | Nitroglycerin results in increased expression of NOS3 protein | CTD | PMID:10625313 more ... |
| nitroglycerin | increases expression | ISO | RGD:3186 | 6480464 | Nitroglycerin results in increased expression of NOS3 protein | CTD | PMID:17541025 PMID:10625313 |
| nitroglycerin | increases expression | ISO | RGD:3186 | 6480464 | Nitroglycerin results in increased expression of NOS3 mRNA | CTD | PMID:10625313 |
| nitroglycerin | increases expression | ISO | RGD:3186 | 6480464 | Nitroglycerin results in increased expression of NOS3 protein | CTD | PMID:10625313 PMID:17541025 |
| nitroglycerin | multiple interactions | ISO | RGD:3186 | 6480464 | Nitroglycerin promotes the reaction [[Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides] | CTD | PMID:10625313 |
| nitroprusside | multiple interactions | EXP | | 6480464 | Nitroprusside inhibits the reaction [Glucose deficiency results in decreased expression of NOS3 protein] | CTD | PMID:17855661 |
| oleic acid | decreases expression | EXP | | 6480464 | Oleic Acid results in decreased expression of NOS3 mRNA | CTD | PMID:16895544 |
| ouabain | multiple interactions | ISO | RGD:3186 | 6480464 | 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide inhibits the reaction [Ouabain results in increased expression of NOS3 protein] | CTD | PMID:15477225 |
| ouabain | affects expression | ISO | RGD:3186 | 6480464 | Ouabain affects the expression of NOS3 protein | CTD | PMID:12384489 |
| ouabain | increases expression | ISO | RGD:3186 | 6480464 | Ouabain results in increased expression of NOS3 protein | CTD | PMID:15477225 |
| ozone | increases expression | ISO | RGD:3186 | 6480464 | Ozone results in increased expression of NOS3 mRNA | CTD | PMID:16081523 |
| ozone | increases expression | ISO | RGD:3186 | 6480464 | Ozone results in increased expression of NOS3 mRNA | CTD | PMID:16081523 PMID:20980218 |
| ozone | increases expression | ISO | RGD:3186 | 6480464 | Ozone results in increased expression of NOS3 mRNA | CTD | PMID:20980218 PMID:16081523 |
| paclitaxel | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Paclitaxel results in decreased expression of NOS3 protein]; more ... | CTD | PMID:19520256 |
| paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of NOS3 protein | CTD | PMID:19520256 |
| paclitaxel | decreases expression | EXP | | 6480464 | Paclitaxel results in decreased expression of NOS3 mRNA | CTD | PMID:19815708 |
| paracetamol | affects expression | ISO | RGD:10997 | 6480464 | Acetaminophen affects the expression of NOS3 mRNA | CTD | PMID:17562736 |
| paracetamol | multiple interactions | ISO | RGD:3186 | 6480464 | Acetaminophen inhibits the reaction [Arsenic results in decreased expression of NOS3 mRNA] | CTD | PMID:22120977 |
| paracetamol | multiple interactions | ISO | RGD:10997 | 6480464 | SU 5416 inhibits the reaction [Acetaminophen results in increased expression of NOS3 protein]; more ... | CTD | PMID:16565415 |
| paracetamol | decreases expression | ISO | RGD:3186 | 6480464 | Acetaminophen results in decreased expression of NOS3 mRNA | CTD | PMID:16172162 |
| paracetamol | increases expression | ISO | RGD:10997 | 6480464 | Acetaminophen results in increased expression of NOS3 protein | CTD | PMID:16565415 |
| paricalcitol | multiple interactions | ISO | RGD:10997 | 6480464 | [paricalcitol co-treated with Enalapril] results in increased expression of NOS3 protein | CTD | PMID:20720404 |
| paricalcitol | increases expression | ISO | RGD:10997 | 6480464 | paricalcitol results in increased expression of NOS3 protein | CTD | PMID:20720404 |
| PD123319 | multiple interactions | EXP | | 6480464 | [PD 123319 binds to and results in decreased activity of AGTR2 protein] inhibits the reaction [candesartan results in increased expression of NOS3 protein] | CTD | PMID:18551021 |
| pentaerythritol tetranitrate | increases expression | ISO | RGD:3186 | 6480464 | Pentaerythritol Tetranitrate results in increased expression of NOS3 protein | CTD | PMID:17541025 |
| perfluorooctane-1-sulfonic acid | increases expression | EXP | | 6480464 | perfluorooctane sulfonic acid results in increased expression of NOS3 mRNA | CTD | PMID:22269386 |
| peroxynitrous acid | multiple interactions | EXP | | 6480464 | Peroxynitrous Acid results in increased nitrosation of and results in decreased activity of NOS3 protein | CTD | PMID:11509453 |
| peroxynitrous acid | multiple interactions | EXP | | 6480464 | SOD1 protein inhibits the reaction [[spermine nitric oxide complex results in increased abundance of Peroxynitrous Acid] which results in increased metabolism of NOS3 protein] | CTD | PMID:12489993 |
| phenylephrine | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to Phenylephrine | CTD | PMID:17403420 |
| phenylephrine | decreases response to substance | ISO | RGD:3186 | 6480464 | NOS3 protein results in decreased susceptibility to Phenylephrine | CTD | PMID:10954898 |
| phenylephrine | multiple interactions | ISO | RGD:3186 | 6480464 | NOS3 protein results in increased susceptibility to [Acetylcholine co-treated with Phenylephrine] | CTD | PMID:10954898 |
| phenylephrine | increases expression | ISO | RGD:3186 | 6480464 | Phenylephrine results in increased expression of NOS3 mRNA; more ... | CTD | PMID:15753950 |
| phenylephrine | affects response to substance | ISO | RGD:3186 | 6480464 | NOS3 protein affects the susceptibility to Phenylephrine | CTD | PMID:11504159 |
| phenylephrine | decreases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in decreased susceptibility to Phenylephrine | CTD | PMID:15381055 |
| phloretin | decreases expression | EXP | | 6480464 | Phloretin results in decreased expression of NOS3 mRNA | CTD | PMID:20021702 |
| phloretin | multiple interactions | EXP | | 6480464 | Phloretin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:20021702 |
| phlorizin | multiple interactions | EXP | | 6480464 | Phlorhizin inhibits the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:20021702 |
| phlorizin | decreases expression | EXP | | 6480464 | Phlorhizin results in decreased expression of NOS3 mRNA | CTD | PMID:20021702 |
| pirinixic acid | multiple interactions | ISO | RGD:3186 | 6480464 | pirinixic acid results in increased expression of and results in increased phosphorylation of NOS3 protein | CTD | PMID:19151258 |
| potassium chloride | multiple interactions | ISO | RGD:3186 | 6480464 | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein; more ... | CTD | PMID:18823320 |
| potassium chloride | decreases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in decreased susceptibility to Potassium Chloride | CTD | PMID:15381055 |
| pravastatin | multiple interactions | ISO | RGD:3186 | 6480464 | Pravastatin promotes the reaction [NOS3 protein binds to NOS3 protein]; more ... | CTD | PMID:17170375 |
| pravastatin | multiple interactions | ISO | RGD:3186 | 6480464 | [resveratrol co-treated with Pravastatin] results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| pravastatin | increases phosphorylation | ISO | RGD:3186 | 6480464 | Pravastatin results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| progesterone | multiple interactions | EXP | | 6480464 | Mifepristone inhibits the reaction [Progesterone results in increased expression of NOS3 protein]; more ... | CTD | PMID:15358673 |
| progesterone | increases expression | ISO | RGD:3186 | 6480464 | Progesterone results in increased expression of NOS3 protein | CTD | PMID:15358673 |
| progesterone | increases activity | ISO | RGD:3186 | 6480464 | Progesterone results in increased activity of NOS3 protein | CTD | PMID:15358673 |
| progesterone | increases phosphorylation | EXP | | 6480464 | Progesterone results in increased phosphorylation of NOS3 protein | CTD | PMID:15358673 |
| progesterone | increases expression | EXP | | 6480464 | Progesterone results in increased expression of NOS3 protein | CTD | PMID:15358673 |
| progesterone | increases activity | EXP | | 6480464 | Progesterone results in increased activity of NOS3 protein | CTD | PMID:15358673 |
| propranolol | affects expression | ISO | RGD:3186 | 6480464 | Propranolol affects the expression of NOS3 | CTD | PMID:10889169 |
| quercetin | multiple interactions | EXP | | 6480464 | Quercetin inhibits the reaction [Lipids results in decreased expression of NOS3] | CTD | PMID:16891912 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of NOS3 mRNA | CTD | PMID:20021702 PMID:21632981 |
| quercetin | increases expression | EXP | | 6480464 | Quercetin results in increased expression of NOS3 mRNA | CTD | PMID:21632981 |
| quercetin | multiple interactions | ISO | RGD:3186 | 6480464 | Quercetin promotes the reaction [Cadmium results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:16226777 |
| quercetin | multiple interactions | ISO | RGD:10997 | 6480464 | [3,5-dimethoxy-4'-hydroxystilbene co-treated with Quercetin] results in increased expression of NOS3 mRNA | CTD | PMID:17135264 |
| quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of NOS3 mRNA | CTD | PMID:15740983 |
| quinapril hydrochloride | affects expression | ISO | RGD:3186 | 6480464 | quinapril affects the expression of NOS3 mRNA | CTD | PMID:12176110 |
| raloxifene | increases expression | ISO | RGD:3186 | 6480464 | Raloxifene results in increased expression of NOS3 mRNA | CTD | PMID:11779577 |
| ramipril | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 protein affects the reaction [Ramipril results in increased abundance of Cyclic GMP] | CTD | PMID:16891913 |
| resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA] | CTD | PMID:22191573 |
| resveratrol | multiple interactions | EXP | | 6480464 | [fulvestrant co-treated with L 663536] inhibits the reaction [resveratrol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:21791144 |
| resveratrol | multiple interactions | EXP | | 6480464 | Cyclodextrins inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:18296501 |
| resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:14990356 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide] | CTD | PMID:22358095 |
| resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12270858 PMID:18716157 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased activity of and results in increased expression of NOS3 protein; more ... | CTD | PMID:12270858 |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of NOS3 protein | CTD | PMID:17278969 PMID:18716157 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS3 mRNA | CTD | PMID:16775512 PMID:20878097 |
| resveratrol | multiple interactions | EXP | | 6480464 | MAP2K5 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:19815564 |
| resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol results in increased activity of and results in increased expression of NOS3 protein | CTD | PMID:21666113 |
| resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:18266981 |
| resveratrol | multiple interactions | ISO | RGD:10997 | 6480464 | [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20675566 |
| resveratrol | increases phosphorylation | ISO | RGD:10997 | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:19478208 |
| resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:20675566 |
| resveratrol | affects activity | ISO | RGD:10997 | 6480464 | resveratrol deficiency affects the activity of NOS3 protein | CTD | PMID:20610621 |
| resveratrol | increases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in increased susceptibility to resveratrol | CTD | PMID:22552115 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:17278969 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 PMID:19846903 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:19846903 PMID:16775512 |
| resveratrol | multiple interactions | EXP | | 6480464 | Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]; more ... | CTD | PMID:19846903 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:17278969 more ... |
| resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 protein; more ... | CTD | PMID:16775512 PMID:17600658 |
| resveratrol | increases phosphorylation | ISO | RGD:3186 | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | [resveratrol co-treated with Pravastatin] results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 mRNA; more ... | CTD | PMID:17600658 PMID:16775512 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased expression of and results in increased activity of NOS3 protein | CTD | PMID:17052855 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 |
| resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:17499741 |
| resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:16775512 more ... |
| resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of NOS3 protein | CTD | PMID:17278969 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:18234130 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:20960276 |
| resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:16775512 |
| resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of NOS3 protein | CTD | PMID:16759640 |
| resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:20067468 PMID:22610192 |
| resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA] | CTD | PMID:20564508 |
| resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol analog results in increased expression of NOS3 mRNA; more ... | CTD | PMID:19066340 |
| resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:18296501 PMID:22314268 |
| resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:16775512 more ... |
| resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:22314268 |
| rosiglitazone | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; more ... | CTD | PMID:19767878 |
| rosiglitazone | increases phosphorylation | EXP | | 6480464 | rosiglitazone results in increased phosphorylation of NOS3 protein | CTD | PMID:18007078 PMID:16527820 |
| rosiglitazone | multiple interactions | ISO | RGD:10997 | 6480464 | rosiglitazone inhibits the reaction [[lipopolysaccharide, E. coli 026-B6 co-treated with TNF protein co-treated with IFNG protein] results in decreased expression of NOS3 mRNA] | CTD | PMID:12566086 |
| rosiglitazone | increases phosphorylation | EXP | | 6480464 | rosiglitazone results in increased phosphorylation of NOS3 protein | CTD | PMID:16527820 PMID:18007078 |
| rosiglitazone | increases phosphorylation | EXP | | 6480464 | rosiglitazone results in increased phosphorylation of NOS3 protein | CTD | PMID:16527820 |
| rosuvastatin | multiple interactions | EXP | | 6480464 | rosuvastatin inhibits the reaction [CRP protein results in decreased expression of NOS3] | CTD | PMID:21562509 |
| rosuvastatin | increases expression | ISO | RGD:3186 | 6480464 | rosuvastatin results in increased expression of NOS3 mRNA | CTD | PMID:15681303 |
| rosuvastatin | increases expression | ISO | RGD:10997 | 6480464 | rosuvastatin results in increased expression of NOS3 mRNA | CTD | PMID:12354446 |
| rosuvastatin | affects response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein affects the susceptibility to rosuvastatin | CTD | PMID:12354446 |
| rosuvastatin | multiple interactions | EXP | | 6480464 | rosuvastatin results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:18162361 |
| rotenone | multiple interactions | EXP | | 6480464 | Rotenone inhibits the reaction [Equol results in increased phosphorylation of and results in increased activity of NOS3 protein] | CTD | PMID:21300668 |
| roxarsone | multiple interactions | EXP | | 6480464 | Roxarsone results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:18414637 |
| scutellarin | increases expression | ISO | RGD:3186 | 6480464 | scutellarin results in increased expression of NOS3 protein | CTD | PMID:16297343 |
| sildenafil | increases expression | ISO | RGD:3186 | 6480464 | sildenafil results in increased expression of NOS3 protein | CTD | PMID:19845545 |
| sildenafil | multiple interactions | ISO | RGD:3186 | 6480464 | [Cisplatin co-treated with sildenafil] results in increased expression of NOS3 mRNA; more ... | CTD | PMID:19152827 |
| sildenafil | increases phosphorylation | ISO | RGD:3186 | 6480464 | sildenafil results in increased phosphorylation of NOS3 protein | CTD | PMID:18373738 |
| sildenafil | multiple interactions | ISO | RGD:3186 | 6480464 | [sildenafil results in increased expression of NOS3 protein] which results in increased secretion of Nitric Oxide | CTD | PMID:19845545 |
| silver atom | multiple interactions | ISO | RGD:3186 | 6480464 | Silver results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:19800954 |
| silver(0) | multiple interactions | ISO | RGD:3186 | 6480464 | Silver results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:19800954 |
| simazine | decreases expression | ISO | RGD:10997 | 6480464 | Simazine results in decreased expression of NOS3 mRNA | CTD | PMID:22984576 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:16375908 |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:10188333 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:16002570 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:11470468 more ... |
| simvastatin | decreases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in decreased expression of NOS3 protein | CTD | PMID:21968084 |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:15711596 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:20737288 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:12379581 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:15711596 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:20737288 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:11470468 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:15711596 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:11470468 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:20493886 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:15711596 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:20659230 more ... |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:20737288 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:15711596 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:18309148 more ... |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 | CTD | PMID:12406854 |
| simvastatin | decreases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in decreased expression of NOS3 mRNA | CTD | PMID:16414398 |
| simvastatin | multiple interactions | ISO | RGD:3186 | 6480464 | Simvastatin inhibits the reaction [Smoke analog affects the expression of NOS3 mRNA] | CTD | PMID:16002570 |
| simvastatin | multiple interactions | ISO | RGD:3186 | 6480464 | Simvastatin inhibits the reaction [Monocrotaline results in increased expression of NOS3 mRNA] | CTD | PMID:22022327 |
| simvastatin | decreases expression | ISO | RGD:10997 | 6480464 | Simvastatin results in decreased expression of NOS3 mRNA | CTD | PMID:11947894 |
| simvastatin | increases expression | ISO | RGD:10997 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:15572054 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 | CTD | PMID:18981156 |
| simvastatin | increases expression | EXP | | 6480464 | Simvastatin results in increased expression of NOS3 mRNA | CTD | PMID:18221806 more ... |
| simvastatin | multiple interactions | EXP | | 6480464 | Mevalonic Acid inhibits the reaction [Simvastatin results in increased expression of NOS3 mRNA] | CTD | PMID:20493886 |
| simvastatin | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]]; more ... | CTD | PMID:20562903 |
| simvastatin | increases phosphorylation | ISO | RGD:3186 | 6480464 | Simvastatin results in increased phosphorylation of NOS3 protein | CTD | PMID:18826357 |
| simvastatin | increases expression | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of NOS3 protein | CTD | PMID:12379581 |
| simvastatin | multiple interactions | ISO | RGD:3186 | 6480464 | Simvastatin results in increased expression of and results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:17335931 |
| sirolimus | multiple interactions | EXP | | 6480464 | Aspirin inhibits the reaction [Sirolimus results in decreased expression of NOS3 protein]; more ... | CTD | PMID:19520256 |
| sirolimus | increases phosphorylation | ISO | RGD:10997 | 6480464 | Sirolimus results in increased phosphorylation of NOS3 protein | CTD | PMID:17261647 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of NOS3 protein | CTD | PMID:19520256 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of NOS3 mRNA | CTD | PMID:19815708 |
| sodium atom | increases expression | ISO | RGD:3186 | 6480464 | Sodium results in increased expression of NOS3 protein | CTD | PMID:16344378 |
| sodium atom | increases phosphorylation | ISO | RGD:3186 | 6480464 | Sodium results in increased phosphorylation of NOS3 protein | CTD | PMID:16344378 |
| sodium atom | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Sodium results in decreased phosphorylation of NOS3 protein | CTD | PMID:16344378 |
| sodium azide | multiple interactions | EXP | | 6480464 | Sodium Azide inhibits the reaction [2-butylamino-2-demethoxy-hypocrellin B results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:17045927 |
| sodium chloride | multiple interactions | ISO | RGD:3186 | 6480464 | [19-oxo-11-deoxycorticosterone acetate co-treated with Potassium Chloride co-treated with Sodium Chloride] results in decreased expression of NOS3 protein; more ... | CTD | PMID:18823320 |
| sodium chloride | decreases expression | ISO | RGD:3186 | 6480464 | Sodium Chloride results in decreased expression of NOS3 protein | CTD | PMID:20232302 |
| sodium chloride | multiple interactions | ISO | RGD:3186 | 6480464 | Losartan inhibits the reaction [Sodium Chloride results in decreased expression of NOS3 protein]; more ... | CTD | PMID:20232302 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | 1-hexacosanol inhibits the reaction [Streptozocin results in decreased expression of NOS3 protein] | CTD | PMID:18528636 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:18266981 |
| streptozocin | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased phosphorylation of NOS3 protein | CTD | PMID:18266981 PMID:21912612 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | Allopurinol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:21912612 |
| streptozocin | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased phosphorylation of NOS3 protein | CTD | PMID:21912612 |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 protein | CTD | PMID:12377873 more ... |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 protein | CTD | PMID:16139267 more ... |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | Cholesterol, Dietary inhibits the reaction [Streptozocin results in increased expression of NOS3 protein] | CTD | PMID:14871415 |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:16045816 more ... |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased activity of and results in decreased phosphorylation of NOS3 protein | CTD | PMID:11696579 |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 mRNA | CTD | PMID:16139267 PMID:22191573 |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:17589825 more ... |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA] | CTD | PMID:22191573 |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 protein | CTD | PMID:19279317 more ... |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:16045816 more ... |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:17589825 more ... |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 protein | CTD | PMID:16139267 more ... |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:18528636 more ... |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 mRNA | CTD | PMID:16139267 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | candesartan inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:16139267 |
| streptozocin | decreases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in decreased expression of NOS3 protein | CTD | PMID:17589825 more ... |
| streptozocin | increases expression | ISO | RGD:3186 | 6480464 | Streptozocin results in increased expression of NOS3 protein | CTD | PMID:19279317 PMID:12377873 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | atorvastatin inhibits the reaction [Streptozocin results in decreased expression of NOS3 protein] | CTD | PMID:17589825 |
| streptozocin | multiple interactions | ISO | RGD:3186 | 6480464 | 8-chlorocarbochromen inhibits the reaction [Streptozocin results in increased expression of NOS3 protein] | CTD | PMID:19279317 |
| sucrose | multiple interactions | ISO | RGD:3186 | 6480464 | Chromium inhibits the reaction [Sucrose results in decreased expression of NOS3 protein] | CTD | PMID:17215582 |
| sucrose | decreases expression | ISO | RGD:3186 | 6480464 | Sucrose results in decreased expression of NOS3 protein | CTD | PMID:17215582 |
| superoxide | multiple interactions | EXP | | 6480464 | 5,6,7,8-tetrahydrobiopterin deficiency inhibits the reaction [NOS3 protein results in increased abundance of Superoxides]; more ... | CTD | PMID:19011239 |
| superoxide | multiple interactions | ISO | RGD:3186 | 6480464 | NOS3 protein affects the reaction [[EDN1 protein co-treated with Calcimycin] results in increased abundance of Superoxides] | CTD | PMID:20977430 |
| superoxide | affects chemical synthesis | EXP | | 6480464 | NOS3 protein affects the chemical synthesis of Superoxides | CTD | PMID:19696404 |
| superoxide | multiple interactions | EXP | | 6480464 | [Equol results in increased chemical synthesis of Superoxides] which results in increased activity of and results in increased phosphorylation of NOS3 protein; more ... | CTD | PMID:21300668 |
| superoxide | decreases abundance | ISO | RGD:3186 | 6480464 | NOS3 protein results in decreased abundance of Superoxides | CTD | PMID:18714161 |
| superoxide | multiple interactions | ISO | RGD:10997 | 6480464 | NOS3 protein affects the reaction [AGT protein results in increased abundance of Superoxides] | CTD | PMID:17272743 |
| superoxide | multiple interactions | ISO | RGD:3186 | 6480464 | [Calcimycin results in increased activity of NOS3 protein] which results in increased abundance of Superoxides; more ... | CTD | PMID:10625313 |
| superoxide | increases abundance | EXP | | 6480464 | NOS3 protein results in increased abundance of Superoxides | CTD | PMID:19011239 |
| tacrolimus hydrate | increases expression | EXP | | 6480464 | Tacrolimus results in increased expression of NOS3 mRNA | CTD | PMID:12352326 |
| tacrolimus hydrate | decreases expression | ISO | RGD:3186 | 6480464 | Tacrolimus results in decreased expression of NOS3 mRNA | CTD | PMID:9931093 |
| tacrolimus hydrate | decreases activity | ISO | RGD:3186 | 6480464 | Tacrolimus results in decreased activity of NOS3 protein | CTD | PMID:9931093 |
| tamoxifen | multiple interactions | ISO | RGD:10997 | 6480464 | Tamoxifen inhibits the reaction [Estradiol results in increased expression of NOS3 mRNA] | CTD | PMID:17873880 |
| telmisartan | multiple interactions | ISO | RGD:10997 | 6480464 | 2-chloro-5-nitrobenzanilide inhibits the reaction [telmisartan results in increased expression of NOS3 protein]; more ... | CTD | PMID:21156825 |
| telmisartan | increases phosphorylation | ISO | RGD:10997 | 6480464 | telmisartan results in increased phosphorylation of NOS3 protein | CTD | PMID:21156825 |
| telmisartan | increases expression | ISO | RGD:10997 | 6480464 | telmisartan results in increased expression of NOS3 protein | CTD | PMID:21156825 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of NOS3 protein | CTD | PMID:21688280 PMID:21843929 |
| testosterone | increases expression | EXP | | 6480464 | Testosterone results in increased expression of NOS3 protein | CTD | PMID:21843929 PMID:21688280 |
| testosterone | affects expression | ISO | RGD:3186 | 6480464 | Testosterone affects the expression of NOS3 mRNA | CTD | PMID:22028410 |
| tetrachloromethane | increases expression | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in increased expression of NOS3 mRNA | CTD | PMID:16325526 PMID:16644059 |
| tetrachloromethane | multiple interactions | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in increased phosphorylation of and results in increased activity of NOS3 protein; more ... | CTD | PMID:18317400 |
| tetrachloromethane | increases expression | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in increased expression of NOS3 protein | CTD | PMID:16325526 |
| tetrachloromethane | increases expression | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in increased expression of NOS3 mRNA | CTD | PMID:16644059 PMID:16325526 |
| tetrachloromethane | decreases phosphorylation | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in decreased phosphorylation of NOS3 protein | CTD | PMID:12891555 |
| tetrachloromethane | decreases expression | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in decreased expression of NOS3 protein | CTD | PMID:12575897 |
| tetrachloromethane | multiple interactions | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in decreased phosphorylation of and results in decreased activity of NOS3 protein | CTD | PMID:18245901 |
| tetrachloromethane | decreases activity | ISO | RGD:3186 | 6480464 | Carbon Tetrachloride results in decreased activity of NOS3 protein | CTD | PMID:12943827 |
| tetrachloromethane | multiple interactions | ISO | RGD:3186 | 6480464 | AKT1 protein inhibits the reaction [Carbon Tetrachloride results in decreased phosphorylation of NOS3 protein] | CTD | PMID:12891555 |
| tetrachloromethane | decreases expression | ISO | RGD:10997 | 6480464 | Carbon Tetrachloride results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:18429990 |
| thioacetamide | multiple interactions | ISO | RGD:3186 | 6480464 | Thioacetamide promotes the reaction [NOS3 protein results in increased chemical synthesis of Nitric Oxide] | CTD | PMID:15207323 |
| thioacetamide | increases expression | ISO | RGD:3186 | 6480464 | Thioacetamide results in increased expression of NOS3 protein | CTD | PMID:15207323 PMID:17276928 |
| thioacetamide | increases expression | ISO | RGD:3186 | 6480464 | Thioacetamide results in increased expression of NOS3 protein | CTD | PMID:17276928 PMID:15207323 |
| thioacetamide | increases expression | ISO | RGD:3186 | 6480464 | Thioacetamide results in increased expression of NOS3 mRNA | CTD | PMID:17276928 |
| toluene | affects expression | ISO | RGD:3186 | 6480464 | Toluene affects the expression of NOS3 mRNA | CTD | PMID:21827849 |
| toluene 2,4-diisocyanate | increases expression | EXP | | 6480464 | Toluene 2,4-Diisocyanate results in increased expression of NOS3 protein | CTD | PMID:12974195 |
| trans-4-coumaric acid | increases expression | EXP | | 6480464 | 4-coumaric acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| trans-resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in increased expression of NOS3 mRNA] | CTD | PMID:22191573 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [fulvestrant co-treated with L 663536] inhibits the reaction [resveratrol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:21791144 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Cyclodextrins inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:18296501 |
| trans-resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:14990356 more ... |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [[Hydrogen Peroxide results in decreased activity of NOS3 protein] which results in decreased chemical synthesis of Nitric Oxide] | CTD | PMID:22358095 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | [resveratrol results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:12270858 PMID:18716157 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased activity of and results in increased expression of NOS3 protein; more ... | CTD | PMID:12270858 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of NOS3 protein | CTD | PMID:17278969 PMID:18716157 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS3 mRNA | CTD | PMID:16775512 PMID:20878097 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | MAP2K5 protein promotes the reaction [resveratrol results in increased expression of NOS3 mRNA]; more ... | CTD | PMID:19815564 |
| trans-resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol results in increased activity of and results in increased expression of NOS3 protein | CTD | PMID:21666113 |
| trans-resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Streptozocin results in decreased phosphorylation of NOS3 protein]; more ... | CTD | PMID:18266981 |
| trans-resveratrol | multiple interactions | ISO | RGD:10997 | 6480464 | [resveratrol results in increased expression of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:20675566 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:10997 | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:19478208 |
| trans-resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:20675566 |
| trans-resveratrol | affects activity | ISO | RGD:10997 | 6480464 | resveratrol deficiency affects the activity of NOS3 protein | CTD | PMID:20610621 |
| trans-resveratrol | increases response to substance | ISO | RGD:10997 | 6480464 | NOS3 protein results in increased susceptibility to resveratrol | CTD | PMID:22552115 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:17278969 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 PMID:19846903 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:15740983 more ... |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:19846903 PMID:16775512 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | Capsaicin promotes the reaction [resveratrol results in increased expression of NOS3 protein]; more ... | CTD | PMID:19846903 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:17278969 more ... |
| trans-resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 protein; more ... | CTD | PMID:16775512 PMID:17600658 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein]; more ... | CTD | PMID:22314268 |
| trans-resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:16775512 more ... |
| trans-resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol analog results in increased expression of NOS3 mRNA; more ... | CTD | PMID:19066340 |
| trans-resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | resveratrol inhibits the reaction [Lysophosphatidylcholines results in decreased expression of NOS3 mRNA] | CTD | PMID:20564508 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein | CTD | PMID:18296501 PMID:22314268 |
| trans-resveratrol | increases expression | ISO | RGD:10997 | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:20067468 PMID:22610192 |
| trans-resveratrol | affects localization | EXP | | 6480464 | resveratrol affects the localization of NOS3 protein | CTD | PMID:16759640 |
| trans-resveratrol | decreases expression | EXP | | 6480464 | resveratrol results in decreased expression of NOS3 mRNA; more ... | CTD | PMID:16775512 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol inhibits the reaction [Glucose results in decreased expression of NOS3 mRNA]; more ... | CTD | PMID:20960276 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol promotes the reaction [Hydrogen Peroxide results in increased expression of NOS3 mRNA] | CTD | PMID:18234130 |
| trans-resveratrol | increases activity | EXP | | 6480464 | resveratrol results in increased activity of NOS3 protein | CTD | PMID:17278969 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 mRNA | CTD | PMID:16775512 more ... |
| trans-resveratrol | increases phosphorylation | EXP | | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:17499741 |
| trans-resveratrol | increases expression | EXP | | 6480464 | resveratrol results in increased expression of NOS3 protein | CTD | PMID:16775512 |
| trans-resveratrol | multiple interactions | EXP | | 6480464 | resveratrol results in increased expression of and results in increased activity of NOS3 protein | CTD | PMID:17052855 |
| trans-resveratrol | increases expression | ISO | RGD:3186 | 6480464 | resveratrol results in increased expression of NOS3 mRNA; more ... | CTD | PMID:17600658 PMID:16775512 |
| trans-resveratrol | multiple interactions | ISO | RGD:3186 | 6480464 | [resveratrol co-treated with Pravastatin] results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| trans-resveratrol | increases phosphorylation | ISO | RGD:3186 | 6480464 | resveratrol results in increased phosphorylation of NOS3 protein | CTD | PMID:17188708 |
| trichloroethene | increases activity | EXP | | 6480464 | Trichloroethylene results in increased activity of NOS3 protein | CTD | PMID:17719164 |
| trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of NOS3 mRNA | CTD | PMID:17719164 |
| trichloroethene | multiple interactions | EXP | | 6480464 | [Trichloroethylene results in increased activity of NOS3 protein] which results in increased chemical synthesis of Nitric Oxide | CTD | PMID:17719164 |
| trimellitic anhydride | decreases expression | ISO | RGD:10997 | 6480464 | trimellitic anhydride results in decreased expression of NOS3 mRNA | CTD | PMID:16141432 |
| troglitazone | increases expression | EXP | | 6480464 | troglitazone results in increased expression of NOS3 mRNA; more ... | CTD | PMID:16949522 |
| ubiquinones | multiple interactions | EXP | | 6480464 | Ubiquinone inhibits the reaction [Glycochenodeoxycholic Acid results in decreased expression of NOS3]; more ... | CTD | PMID:20020783 |
| uranium atom | multiple interactions | ISO | RGD:3186 | 6480464 | [[Uranium results in decreased activity of NOS2 protein] co-treated with [Uranium results in increased activity of NOS3 protein]] results in decreased abundance of Nitrates; more ... | CTD | PMID:17566059 |
| uranium atom | decreases expression | ISO | RGD:3186 | 6480464 | Uranium results in decreased expression of NOS3 mRNA | CTD | PMID:17566059 |
| uranium atom | increases activity | ISO | RGD:3186 | 6480464 | Uranium results in increased activity of NOS3 protein | CTD | PMID:17566059 |
| urethane | multiple interactions | ISO | RGD:10997 | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of NOS3 mRNA | CTD | PMID:12400877 |
| urethane | increases expression | ISO | RGD:10997 | 6480464 | Urethane results in increased expression of NOS3 mRNA | CTD | PMID:12400877 |
| valsartan | multiple interactions | ISO | RGD:10997 | 6480464 | valsartan inhibits the reaction [Oxygen deficiency results in increased phosphorylation of NOS3 protein] | CTD | PMID:18436887 |
| valsartan | multiple interactions | ISO | RGD:3186 | 6480464 | valsartan inhibits the reaction [Oxygen deficiency promotes the reaction [AGT protein results in increased expression of NOS3 protein]] | CTD | PMID:11897773 |
| vanadium atom | increases expression | EXP | | 6480464 | Vanadium results in increased expression of NOS3 mRNA | CTD | PMID:19000753 |
| vanadium(0) | increases expression | EXP | | 6480464 | Vanadium results in increased expression of NOS3 mRNA | CTD | PMID:19000753 |
| vanillic acid | increases expression | EXP | | 6480464 | Vanillic Acid results in increased expression of NOS3 mRNA | CTD | PMID:15740983 |
| wortmannin | multiple interactions | EXP | | 6480464 | Fenofibrate inhibits the reaction [wortmannin results in decreased phosphorylation of NOS3 protein] | CTD | PMID:16442496 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [resveratrol results in increased phosphorylation of and results in increased activity of NOS3 protein] | CTD | PMID:18296501 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Progesterone promotes the reaction [Estradiol results in increased activity of NOS3 protein]]; more ... | CTD | PMID:15358673 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased phosphorylation of NOS3 protein]]; more ... | CTD | PMID:19767878 |
| wortmannin | decreases phosphorylation | EXP | | 6480464 | wortmannin results in decreased phosphorylation of NOS3 protein | CTD | PMID:16442496 |
| wortmannin | multiple interactions | ISO | RGD:3186 | 6480464 | wortmannin affects the reaction [Carbon Tetrachloride results in increased phosphorylation of and results in increased activity of NOS3 protein] | CTD | PMID:18317400 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [Nifedipine promotes the reaction [[Hydrogen Peroxide co-treated with Simvastatin] results in increased phosphorylation of and results in increased expression of NOS3 protein]]; more ... | CTD | PMID:20562903 |
| wortmannin | multiple interactions | EXP | | 6480464 | wortmannin inhibits the reaction [arsenite results in increased phosphorylation of and results in increased activity of NOS3 protein] | CTD | PMID:11788791 |
| zinc atom | increases expression | ISO | RGD:3186 | 6480464 | Zinc deficiency results in increased expression of NOS3 | CTD | PMID:20128680 |
| zinc(0) | increases expression | ISO | RGD:3186 | 6480464 | Zinc deficiency results in increased expression of NOS3 | CTD | PMID:20128680 |